The Agenda
Agenda – What’s on when
12:00 – 1:00
Registration and Check-in
1:00 – 1:20
Opening Conference Remarks
David Swoboda, MD – Director, Leukemia Program, Tampa General Hospital Cancer Institute
Gustavo Rivero, MD, – Director, Translational Research for Hematologic Malignancies, Tampa General Hospital Cancer Institute
1:20 – 2:20
Session: Racial & Ethnic Disparities in Malignant Hematology
Session Chair
Gustavo Rivero, MD, – Director, Translational Research for Hematologic Malignancies, Tampa General Hospital Cancer Institute
1:20-1:40
Ann-Kathrin Eisfeld, MD – Director, Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center
1:40-2:00
Lars Hernandez Nielsen, PhD– Assistant Professor, Danish Center for Health Services Research, Denmark
2:00-2:20
Gustavo Rivero, MD, – Director, Translational Research for Hematologic Malignancies, Tampa General Hospital Cancer Institute
Ann-Kathrin Eisfeld, MD – Director, Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center
Lars Hernandez Nielsen, PhD– Assistant Professor, Danish Center for Health Services Research, Denmark
2:20 – 2:30
Coffee Break
2:30 – 4:10
Session: AI/Computational Biology in Hematology
Session Chair
Aziz Nazha, MD –Hematologist-Oncologist, Sidney Kimmel Cancer Center, Jefferson Health — Cherry Hill, New Jersey
2:30-2:50
Nishit Patel, MD – Professor, Dermatology and Cutaneous Surgery, USF Health Morsani College of Medicine
2:50-3:10
Maher Albitar, MD –Founder; Chief Executive Officer; Chief Medical Officer, Genomic Testing Cooperative
3:10-3:30
David Swoboda, MD – Director, Leukemia Program, Tampa General Hospital Cancer Institute
3:30-3:50
Aziz Nazha, MD –Hematologist-Oncologist, Sidney Kimmel Cancer Center, Jefferson Health — Cherry Hill, New Jersey
Nishit Patel, MD – Professor, Dermatology and Cutaneous Surgery, USF Health Morsani College of Medicine
Maher Albitar, MD –Founder; Chief Executive Officer; Chief Medical Officer, Genomic Testing Cooperative
David Swoboda, MD – Director, Leukemia Program, Tampa General Hospital Cancer Institute
4:00-4:50
Abstract Session
Friday – May 8, 2026
7:30-9:00
Registration and Check-in – Light Breakfast
8:00-8:10
Welcome & Housekeeping
Steering Committee
David Swoboda, MD – Director, Leukemia Program, Tampa General Hospital Cancer Institute
Gustavo Rivero, MD – Director, Translational Research for Hematologic Malignancies, Tampa General Hospital Cancer Institute
8:10 – 10:10
Session: Myeloid
Session Chair
David Swoboda, MD – Director, Leukemia Program, Tampa General Hospital Cancer Institute
8:10-8:30
Eunice Wang, MD –Chief, Leukemia Service & Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center
8:30-8:50
Nicholas James Short, MD – Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
8:50-9:10
Hetty E. Carraway, MD, MBA – Professor of Medicine; Member, Immune Oncology Program, Case Comprehensive Cancer Center
9:10-9:20
Logan Murray, PA – Certified Physician Assistant, Tampa General Hospital Cancer Institute
Maher Albitar, MD –Founder; Chief Executive Officer; Chief Medical Officer, Genomic Testing Cooperative
9:20-9:30
Logan Murray, PA – Certified Physician Assistant, Tampa General Hospital Cancer Institute
Maher Albitar, MD –Founder; Chief Executive Officer; Chief Medical Officer, Genomic Testing Cooperative
9:30-10:00
David Swoboda, MD – Director, Leukemia Program, Tampa General Hospital Cancer Institute
Eunice Wang, MD –Chief, Leukemia Service & Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center
Nicholas James Short, MD – Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Hetty E. Carraway, MD, MBA – Professor of Medicine; Member, Immune Oncology Program, Case Comprehensive Cancer Center
Maher Albitar, MD –Founder; Chief Executive Officer; Chief Medical Officer, Genomic Testing Cooperative
Logan Murray, PA – Certified Physician Assistant, Tampa General Hospital Cancer Institute
10:00 – 10:25
Coffee Break
10:25-12:15
Session: Lymphoid
Session Chair
Alan Kerr, II, MD, PhD – Hematologist-Oncologist; Physician Scientist, Tampa General Hospital Cancer Institute
10:25-10:45
Julio Chavez, MD, MS – Senior Associate Consultant, Division of Hematology/Oncology,
Mayo Clinic — Jacksonville, Florida
10:45-11:05
Andre Goy, MD –Physician-in-Chief, Oncology Services, Hackensack Meridian Health
11:05-11:25
Jonathan Moreira, MD – Associate Professor of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University
11:25-11:35
Alan Kerr, II, MD, PhD – Hematologist-Oncologist; Physician Scientist, Tampa General Hospital Cancer Institute
Maher Albitar, MD –Founder; Chief Executive Officer; Chief Medical Officer, Genomic Testing Cooperative
11:35-11:45
Jerrin Joy Pullukkara, MBBS – Oncology Fellow, USF Health Morsani College of Medicine
Maher Albitar, MD –Founder; Chief Executive Officer; Chief Medical Officer, Genomic Testing Cooperative
11:45-12:15
Alan Kerr, II, MD, PhD – Hematologist-Oncologist; Physician Scientist, Tampa General Hospital Cancer Institute
Julio Chavez, MD, MS – Senior Associate Consultant, Division of Hematology/Oncology,
Mayo Clinic — Jacksonville, Florida
Jonathan Moreira, MD – Associate Professor of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University
Andre Goy, MD –Physician-in-Chief, Oncology Services, Hackensack Meridian Health
Maher Albitar, MD –Founder; Chief Executive Officer; Chief Medical Officer, Genomic Testing Cooperative
Jerrin Joy Pullukkara, MBBS – Oncology Fellow, University of South Florida Morsani School of Medicine
12:15-12:45
Lunch / Exhibits
12:45-1:25
Non-CME Session
1:25-1:55
Break / Exhibits
1:55-2:10
Abstract Presentations
2:10-4:00
Session: Myeloma
Session Chair
Ivan Marques Borrello, MD – Medical Director, Myeloma, Bone Marrow Transplant and Cell Therapies Program, Tampa General Hospital Cancer Institute
2:10-2:30
Madhav Dhodapkar, MBBS – Professor, Translational Science & Therapeutics Division, Scientific Director, Multiple Myeloma Program, Milton B. Rubin Family Endowed Chair, Fred Hutchinson Cancer Center
22:30-2:50
Robert Z. Orlowski, MD, PhD –Director, Myeloma Section, The University of Texas MD Anderson Cancer Center
2:50-3:10
Ankit Kansagra, MD, Hematologist-Oncologist, Physician Scientist, Tampa General Hospital Cancer Institute
3:10-3:20
Ivan Marques Borrello, MD – Medical Director, Myeloma, Bone Marrow Transplant and Cell Therapies Program, Tampa General Hospital Cancer Institute
3:20-3:30
Jennifer Hanle, MSN, AGPCNP-BC– Nurse Practitioner, Multiple Myeloma, Bone Marrow Transplant and Cell Therapy Programs, Tampa General Hospital Cancer Institute
3:30-4:00
Ivan Marques Borrello, MD – Medical Director, Myeloma, Bone Marrow Transplant and Cell Therapies Program, Tampa General Hospital Cancer Institute
Madhav Dhodapkar, MBBS – Professor, Translational Science & Therapeutics Division, Scientific Director, Multiple Myeloma Program, Milton B. Rubin Family Endowed Chair, Fred Hutchinson Cancer Center
Robert Z. Orlowski, MD, PhD –Director, Myeloma Section, The University of Texas MD Anderson Cancer Center
Ankit Kansagra, MD, Hematologist-Oncologist, Physician Scientist, Tampa General Hospital Cancer Institute
Jennifer Hanle, MSN, AGPCNP-BC– Nurse Practitioner, Multiple Myeloma, Bone Marrow Transplant and Cell Therapy Programs, Tampa General Hospital Cancer Institute
4:00
